Front. Chem. Biol. Frontiers in Chemical Biology Front. Chem. Biol. 2813-530X Frontiers Media S.A. 1729141 10.3389/fchbi.2025.1729141 Perspective Tailoring LC approaches to address the chemical biology of toxic metals in humans Gailer 10.3389/fchbi.2025.1729141 Gailer Jürgen * Conceptualization Funding acquisition Project administration Resources Supervision Visualization Writing - original draft Writing - review and editing Department of Chemistry, University of Calgary, Calgary, AB, Canada Correspondence: Jürgen Gailer, jgailer@ucalgary.ca 05 01 2026 2025 4 1729141 21 10 2025 18 11 2025 11 12 2025 Copyright © 2026 Gailer. 2026 Gailer https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

The global contamination of ∼15% of agricultural soils with toxic metal (loid) species (TMS) including arsenic, cadmium, mercury, and nickel compromises food safety and chronically exposes millions of people to these inorganic pollutants which are absorbed into the bloodstream to various degrees. The health ramifications that pertain to this arguably biggest problem in the postgenomic world remain poorly defined, particularly with regard to babies, children, pregnant women and industrial workers. To better understand the underlying complex exposure-response relationship, it is crucial to address chemical biology related research questions unfolding within the blood-organ nexus. Since the associated complexity makes it particularly challenging to causally link human exposure to exceedingly small daily TMS doses with adverse health effects and environmental diseases, the use of appropriate analytical tools is paramount. One research tool whose full potential to probe dynamic bioinorganic processes has not yet been fully recognized is liquid chromatography (LC). Recent results will be used to highlight how LC methods can be tailored to address chemical biology questions pertaining to toxic mercury and cadmium species at near physiological conditions. It will be argued that the inherent versatility of LC methods makes it eminently suitable to tackle questions regarding the exposure-response relationship of other emerging TMS to more effectively deal with this emerging public health crisis.

 cadmium mercury nickel manganese element-specific detection separation mechanism mechanism of chronic toxicity Natural Sciences and Engineering Research Council of Canada 10.13039/501100000038 The author(s) declared that financial support was received for this work and/or its publication. Some of the research covered in this perspective was funded by a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant of Canada to JG. section-at-acceptance Bioinorganic Chemistry Introduction

It is estimated that 9 million people died of pollution related causes in 2015 (Fuller et al., 2022). Since 14–17% of agricultural soils globally are contaminated with toxic metal species (TMS), such as Ni, Cd, Hg and Pb (Hou et al., 2025), the ingestion of contaminated food affects millions of people worldwide (Ugulu et al., 2025). The subsequent influx of TMS from the gastrointestinal tract into the bloodstream urgently requires a better understanding of the associated adverse health ramifications that will eventually the unfold at the organ level. To this end, the biomolecular mechanisms which explain why any given toxic metal species (TMS) causes organ damage and/or a disease were well posed, but unsolved problems 50 years ago (Passow et al., 1961), and largely remain so today. Even though immense progress has been made in terms of elucidating relevant biomolecular mechanisms of action (Aschner et al., 2022), we are still unable to reasonably predict how much of an orally ingested TMS dose–in form of contaminated food and/or drinking water - actually reaches toxicological target organs to disrupt vital cellular processes therein (Doroudian and Gailer, 2022). In addition, there is no strategy about how we should address the exposure of humans to multiple TMS which can interfere with the metabolism of essential elements in different biological compartments (Sarpong-Kumankomah et al., 2018).

Three conceptual approaches are currently being explored to better understand the exposure-response relationship of TMS, including epidemiology (Bobb et al., 2015), systems toxicology (Sturla et al., 2014) and mechanism based approaches (Gailer, 2024). Among these approaches the latter hinges on better understanding the bioinorganic chemistry of TMS in the bloodstream-organ nexus, which remains woefully incomplete as humans have 79 organs which are - to borrow a term from chemistry – ‘decoupled’ from the bloodstream. Disentangling the aforementioned bioinorganic processes therefore represents a viable strategy to causally link human exposure to TMS with the etiology of adverse effects and the etiology of diseases which is exemplified by the focus of the journal ‘Blood Cells, Molecules & Diseases’. In this context, the arguably biggest knowledge gaps are processes of TMS that unfold in plasma as well as within red blood cells (RBCs) and to then connect the outcome of these interrelated processes (e.g., RBC rupture) with what unfolds at target organs (Figure 1).

Conceptual depiction of the biochemical fate of TMS in the bloodstream which collectively define their exposure-response relationship. Detoxification reactions of TMS in the bloodstream include (A) their interaction with essential elements (e.g., selenium), (B) their ad/absorption to/into red blood cells, (C) their ad/absorption by/into endothelial cells and (D) their binding to plasma transport proteins. Any residual TMS will interact with ligands in blood plasma to form organ available complexes that are then translocated into toxicological target organ cells. Note that all processes (A–E) effectively constitute selectivity filters which protect internal organs from the influx of TMS. Only if the TMS dose exceeds the detoxification capacity of A-D will they be able to enter target organs to cause organ damage. Adapted with permission from Toxics, 13, 636 by M.F. Degorge and J. Gailer.

Diagram illustrating the detoxification and processing of toxic metals (TMs) in the body. The process begins in the gastrointestinal tract with detoxification by trace elements. In the blood, TMs are sequestered by red blood cells and epithelial cells, followed by plasma protein binding. The target organ cell then experiences TM-induced organ damage. The flow is depicted with arrows through stages: exposure, organ deposition and excretion, detoxification, organ availability, and response.

To uncover relevant toxicological chemistry processes of TMS in the bloodstream, three interrelated problems need to be addressed, namely, the inherent complexity of this biological fluid (plasma contains up to 40,000 proteins and RBC cytosol up 1800 proteins), the fact that its background electrolyte corresponds to 100 mM Cl− and the notion that the redox environment in which relevant processes unfold differs fundamentally between plasma (oxidizing environment) and RBCs (reducing environment). Probing the chemical biology of TMS in the bloodstream-organ system therefore requires one to incorporate these facts into the experimental design and – perhaps most importantly - to select the most adequate research methods to close existing knowledge gaps (Gailer, 2024).

This perspective aims to explain in what way LC-methods offer versatility to address diverse bioinorganic chemistry-questions that relate to the interaction of TMS with biomolecules at near physiological conditions. After highlighting recent examples which illustrate how LC-methods can be tailored to address their translocation from the bloodstream to organs and to probe the biomolecular degradation of a pharmaceutically relevant TMS, the potential of applying LC-methods to other bioinorganic chemistry problems will be discussed.

 Why are LC-methods suited to address bioinorganic questions pertaining to TMS?

Since dynamic toxicological chemistry-related processes of TMS that unfold within organisms involve aqueous environments, LC-methods should be intrinsically well suited to probe these processes using water-based physiological buffers, such as phosphate-buffered saline (PBS)-buffer. LC-methods offer four unique capabilities that go beyond the mere separation of complex mixtures of biomolecules which makes them particularly useful to study interactions between TMS and ligands at near physiological conditions. These capabilities include their intrinsic ability to observe a) the on-column formation of complexes between metal (loid)s that are injected and ligands that are dissolved in the mobile phase (Liska et al., 1979; Pourzadi and Gailer, 2024), b) the temporal stability of molecular constituents in liquid formulations [e.g., the organomercury bactericidal agent thimerosal in vaccines to establish their shelf-life; (Reader and Lines, 1983)], c) the stability of metal-based compounds in biological fluids [e.g., thimerosal in red blood cell cytosol (Gibson et al., 2017)] as well as metal-based anticancer drugs (e.g., cisplatin and carboplatin) in blood plasma (Sooriyaarachchi et al., 2011) and – perhaps most importantly - d) a shift of the retention time of an on-column formed TMS species based on employing different LC-based separation mechanisms, namely, size exclusion chromatography (SEC), anion-exchange chromatography (AEX) and/or reversed phase chromatography (RPC). Thus, the utilization of physiological buffers in conjunction with LC-methods and appropriate element-specific detectors (e.g., flame atomic absorption spectrometry or inductively coupled plasma atomic emission spectroscopy) should therefore allow to obtain new insight into the toxicological chemistry of TMS species at near physiological conditions.

 Top-down and bottom-up LC approaches to probe the bioinorganic chemistry of TMS

The interaction of TMS with biomolecules can be probed using top-down or bottom-up approaches (Gailer, 2013). The top-down approach refers to the direct LC-analysis of biological fluids to which a TMS has been added using mobile phases that mimick its background electrolyte using appropriate buffer salts (Jahromi et al., 2010). SEC, for example, tolerates the injection of blood plasma when PBS-buffer is used (Manley et al., 2009), while RBC cytosol was analyzed using a 0.1 M Tris buffer which contained 2.5 mM GSH (Gibson et al., 2017) to simulate the RBC cytosol concentration. Conversely, the bottom-up approach can be employed to simulate a specific bioinorganic chemistry reaction, such as the binding of an injected TMS onto a column with a ligand that is dissolved in physiological buffer as the mobile phase (Pourzadi and Gailer, 2024).

 Application of LC-methods to address bioinorganic TMS problems

To date, SEC, AEX and RPC have been successfully employed to probe bioinorganic processes of TMS at the bloodstream-organ nexus in a top-down (TD) and a bottom-up (BU) manner.

Formation of organ available TMS metabolites in plasma SEC reveals a MeHg<sup>+</sup> metabolite that is delivered to the blood brain barrier (TD)

While MeHg+ has long been known to be neurotoxic, the structure of the organ available metabolite that is formed in plasma and enters the brain has been elusive. To gain insight, the utilization of a PBS-buffer mobile phase and the analysis of rabbit plasma that had been spiked with MeHg+ revealed the elution of a rabbit serum albumin (RSA)-MeHg complex (Bridle et al., 2022). Since small molecular weight (SMW) thiols, such as homo-L-cysteine (hCys) are present in blood plasma at 10–15 μM, the mobilization of MeHg+ from its RSA binding sites was investigated by gradually increasing the hCys mobile phase concentration from 50 to 300 μM and injecting MeHg-spiked rabbit plasma. The results revealed that the 50 μM hCys containing mobile phase shifted the retention time of MeHg from the protein elution range to the SMW elution range, implying the on-column formation of a MeHg-hCys complex. The formation of the latter complex was confirmed by electrospray ionization-mass spectrometry (ESI-MS). The presence of L-amino acid transporters 1 (LAT-1/2) at the blood-brain-barrier was previously demonstrated to recognize structurally closely related MeHg-Cys complexes. Thus, the observed formation of MeHg-hCys complexes at near physiological conditions of blood plasma provides a feasible pathway by which MeHg+ is delivered to the brain (Figure 2), where adverse biochemical processes including the inhibition of the selenoprotein glutathione peroxidase 4 (GPx) will then unfold (Chen et al., 2023).

Conceptual depiction of the important role that LC-methods are destined to play in terms of better understanding the bioinorganic chemistry of TMS in the bloodstream-organ system.

Diagram illustrating the relationship between chemistry and biology in HPLC analysis. The top section shows a high-performance liquid chromatography setup with components like a syringe, pump, and detector. The bottom section illustrates bioinorganic interactions of toxic metals (TMs) with HSA (human serum albumin) and molecules such as homocysteine (hCys), cysteine (Cys) and glutathione (GSH). Labels indicate the brain and kidney, highlighting possible effects and pathways, with symbols for different metal species like MeHg+, Cd2+ and/or thimerosal (THI). Arrows show chemical reactions and pathways. AEX identifies Cd<sup>2+</sup> metabolites that are delivered to the kidneys (BU)

Although Cd2+ has long been known to be a nephrotoxin, the organ available metabolite(s) that is/are formed in plasma has/have remained elusive, but likely involves the formation of Cys-complexes (Bridges and Zalups, 2017). The application of AEX in conjunction with a mobile phase comprised of 100 mM NaCl and 5.0 mM Tris-buffer (pH 7.4) allowed to observe the elution of the injected Cd2+ species. Since Cys is implicated in the translocation of Cd2+ from blood plasma to the kidneys, Cd2+ was then chromatographed with mobile phases containing increasing Cys concentrations between 0.1 and 10 mM (Gautam et al., 2023). The Cd-species that eluted with the 100 and 200 μM Cys mobile phase were then structurally characterized by X-ray absorption spectroscopy. The results revealed a mixture of Cd species with tetrahedral coordination suggesting the formation of [Cd(Cys)1/2]+1 complexes which may represent the nephrotoxic species that are then uptaken by the kidneys (Figure 2) to induce cellular damage by processes that are still incompletely understood (Thevenod and Lee, 2024).

 RPC reveals the GSH mediated degradation of a pharmaceutical TMS at pH 7.4 (BU)

The bactericidal organomercurial thimerosal (THI) has been used as a vaccine additive since the 1950s. Since vaccines are intramuscularly injected, THI will therefore interact with mammalian cells (e.g., RBCs) and the biological thiols therein. The donation of the ethylmercury (EtHg+) moiety from THI to mammalian proteins that contain surface accessible contain thiol groups (Geri et al., 2024), however, has not been observed at physiologically relevant conditions. Since GSH is present in RBC cytosol at ∼2.5 mM, a LC-method was developed (Le et al., 2025) which allowed to observe the GSH-mediated degradation of THI (Degorge et al., 2025). In brief, the addition of increasing GSH concentrations to the mobile phase (2.5–15.0 mM) resulted in a decrease of the Hg peak corresponding to THI and the elution of a new Hg-peak with a shorter retention time. With the 15 mM GSH mobile phase, two Hg-peaks were detected which displayed equal intensities. The elucidation of the molecular structure of the unknown Hg peak by ESI-MS revealed a GS-HgEt adduct, which allowed to propose a degradation mechanism for THI at pH 7.4 (Degorge et al., 2025), which may unfold in RBCs (Figure 2). While the GSH-mediated degradation of THI was observed in the presence of 30% of acetonitrile, these results serve as an important starting point to better understand the side-effects of THI, such as the transfer of the EtHg-moiety from the GS-EtHg adduct to other cytosolic proteins.

 Discussion

The application of SEC and AEX allowed the structural characterization of organ available MeHg+ and Cd2+ metabolites that are formed in plasma, while the application of RPC revealed the mechanism by which GSH degrades the vaccine additive thimerosal. Taken together these findings are highly relevant to better understand the exposure-response relationship related to the exposure of humans to TMS (Zhang et al., 2025). The emerging exposure of human populations to other metals of high technological relevance, such as Ni2+ (Parveen et al., 2025) and Mn2+ (Deng et al., 2024) will similarly require a better understanding of the corresponding bioinorganic processes to develop cheap palliative measures to mitigate their impact (Parveen et al., 2025) as they already compromise food security on a global scale (Ugulu et al., 2025). The application of LC-methods in conjunction with other advanced instrumental analytical methods (Weng et al., 2024) and metalloproteomic approaches (Zhou et al., 2022) thus represent a useful addition to the existing analytical toolbox to uncover the mechanism-integrated framework which links human exposure to multiple TMS with the etiology of environmental diseases (Gailer, 2024; Leung et al., 2024) and are destined to play an important role to foster the development of more effective strategies to globally reduce their adverse impact on human health (Gulma, 2025).

 Ethics statement

The withdrawal of blood from rabbits to obtain blood plasma and red blood cells was approved by the Conjoint Health Ethics Board of the University of Calgary. The study was conducted in accordance with the local legislation and institutional requirements.

 Author contributions

JG: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review and editing.

 Acknowledgements

The author greatly acknowledges Mathew Sara for generating Figure 2 and funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada.

 Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The reviewer LM declared a past co-authorship with the author JG to the handling editor.

 Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Edited by: Antonello Merlino, University of Naples Federico II, Italy

Reviewed by: Luigi Messori, University of Florence, Italy

 References Aschner M. Skalny A. V. Martins A. C. Sinitskii A. I. Farina M. Lu R. (2022). Ferroptosis as a mechanism of non-ferrous metal toxicity. Arch. Toxicol. 96, 2391–2417. 10.1007/s00204-022-03317-y 35727353 Bobb J. F. Valeri L. Claus Henn B. Christiani D. C. Wright R. O. Mazumdar M. (2015). Bayesian kenel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics 16, 493–508. 10.1093/biostatistics/kxu058 25532525 Bridges C. C. Zalups R. K. (2017). Mechanisms involved in the transport of mercuric ions in target tissues. Arch. Toxicol. 91, 63–81. 10.1007/s00204-016-1803-y 27422290 Bridle T. G. Doroudian M. White W. Gailer J. (2022). Physiologically relevant hCys concentrations mobilize MeHg from rabbit serum albumin to form MeHg-hCys complexes. Metallomics 14, mfac010. 10.1093/mtomcs/mfac010 35150279 Chen J. Ma M. Wang R. Gao M. Hu L. G. Liu S. (2023). Roles of glutathione peroxidase 4 on the mercury-triggered ferroptosis in renal cells: implications for the antagonism between selenium and Mercury. Metallomics 15, mfad014. 10.1093/mtomcs/mfad014 36869799 Degorge M. F. Mertz S. Gailer J. (2025). Degradation of the vaccine additive thimerosal by L-glutathione and L-cysteine at physiological pH. Inorganics 13, 280. 10.3390/inorganics13090280 Deng X. Guo Y. Jin X. Si H. Dai K. Deng M. (2024). Manganese accumulation in red blood cells as a biomarker of manganese exposure and neurotoxicity. Neurotoxicology 102, 1–11. 10.1016/j.neuro.2024.03.003 38461971 Doroudian M. Gailer J. (2022). Integrative metallomics studies of toxic metal(loid) substances at the blood plasma-red blood cell-organ/tumor nexus. Inorganics 10, 200. 10.3390/inorganics10110200 Fuller R. Landrigan P. J. Balakrishnan K. Bathan G. Bose-O'Rielly S. Brauer M. (2022). Pollution and health: a progress update. Lancet Planet Health 6, e535–e547. 10.1016/S2542-5196(22)00090-0 35594895 Gailer J. (2013). Metal species in biology: bottom-up and top-down LC approaches in applied toxicological research. ISRN Chromatogr. 2013, 21. 10.1155/2013/801840 Gailer J. (2024). Toward a mechanim-driven integrated framework to link human exposure to multiple toxic metal(loid) species with environmental diseases. Int. J. Mol. Sci. 25, 3393. 10.3390/ijms25063393 38542366 Gautam A. Gomez A. Mendoza Rengifo E. George G. N. Pickering I. J. Gailer J. (2023). Structural characterization of toxicologically relevant Cd2+-L-Cysteine complexes. Toxics 11, 294. 10.3390/toxics11040294 37112521 Geri A. Zineddu S. Massai L. Ronga L. Lobinski R. Gailer J. (2024). Mercury binding to proteins disclosed by ESI MS experiments: the case of three organomercurials. J. Inorg. Biochem. 252, 112479. 10.1016/j.jinorgbio.2024.112479 38218139 Gibson M. A. Sarpong-Kumankomah S. Nehzati S. George G. N. Gailer J. (2017). Remarkable differences in the biochemical fate of Cd2+, Hg2+, CH3Hg+ and thimerosal in red blood cell lysate. Metallomics 9, 1060–1072. 10.1039/c7mt00069c 28702563 Guma K. A. (2025). Health systems strategies to reduce global impacts of toxic substance exposure. Acad. Med. 2, 1–7. 10.20935/acadmed7562 Hou D. Jia X. Wang L. McGrath S. P. Zhu Y.-G. Hu Q. (2025). Global soil pollution by toxic metals threatens agriculture and human health. Science 388, 316–321. 10.1126/science.adr5214 40245139 Jahromi E. Z. White W. Wu Q. Yamdagni R. Gailer J. (2010). Remarkable effect of mobile phase buffer on the SEC-ICP-AES derived Cu, Fe and Zn-metalloproteome pattern of rabbit blood plasma. Metallomics 2, 460–468. 10.1039/c003321a 21072345 Le M. V. K. Pourzadi N. Gailer J. (2025). Retention behavior of Hg2+, MeHg+, thimerosal and phenylmercuric acetate on a C18 RP-HPLC column. J. Chromatogr. A 1739, 465546. 10.1016/j.chroma.2024.465546 39608236 Leung J.W.-H. Loan A. Xu Y. Yang G. Wang J. Chan H. M. (2024). Reduction of glyoxalate 1 expression links fetal methylmercury exposure to autism spectrum disorder pathogenesis. Toxics 12, 449. 10.3390/toxics12070449 39058101 Liska O. Lehotay J. Brandsteterova E. Guiochon G. (1979). Liquid chromatography of metal complexes of N-substituted dithiocarbamic acids. J. Chromatogr. 171, 153–159. 10.1016/S0021-9673(01)95295-1 Manley S. A. Byrns S. Lyon A. W. Brown P. Gailer J. (2009). Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by size-exclusion chromatography-inductively coupled plasma atomic emission spectroscopy. J. Biol. Inorg. Chem. 14, 61–74. 10.1007/s00775-008-0424-1 18781345 Parveen S. Rizvi A. Naseem I. (2025). Vitamin C prevents nickel accumulation in rat brain through affecting its transport via serum albumin. Biochem. Biophys. Res. Commun. 777, 152314. 10.1016/j.bbrc.2025.152314 40628049 Passow H. Rothstein A. Clarkson T. W. (1961). The general pharmacology of the heavy metals. Pharmacol. Rev. 13, 185–224. 10.1016/s0031-6997(25)07018-8 13733187 Pourzadi N. Gailer J. (2024). L-Cysteine mediated rapid baseline separation of Hg2+ and MeHg+ by anion-exchange HPLC. J. Chromatogr. A 1735, 465309. 10.1016/j.chroma.2024.465309 39241401 Reader M. J. Lines C. B. (1983). Decomposition of thimerosal in aqueous solution and its determination by high-performance liquid chromatography. J. Pharm. Sci. 72, 1406–1409. 10.1002/jps.2600721210 6663475 Sarpong-Kumankomah S. Gibson M. A. Gailer J. (2018). Organ damage by toxic metals is critically determined by the bloodstream. Coord. Chem. Rev. 374, 376–386. 10.1016/j.ccr.2018.07.007 Sooriyaarachchi M. Narendran A. Gailer J. (2011). Comparative hydrolysis and plasma binding of cis-platin and carboplatin in human plasma in vitro . Metallomics 3, 49–55. 10.1039/c0mt00058b 21135941 Sturla S. J. Boobis A. R. Fitzgerald R. E. Hoeng J. Kavlock R. J. Schirmer K. (2014). Systems toxicology: from basic research to risk assessment. Chem. Res. Toxicol. 27, 314–329. 10.1021/tx400410s 24446777 Thevenod F. Lee W.-K. (2024). Cadmium transport by mammalian ATP-binding cassette transporters. Biometals 37, 697–719. 10.1007/s10534-024-00582-5 38319451 Ugulu I. Khan Z. I. Ahmad K. Iqbal U. Ashfar A. Memona H. (2025). Heavy metal accumulation and cross-matirx relationships in semi-arid livestock systems. J. Food Compos. Analysis 148, 108255. 10.1016/j.jfca.2025.108255 Weng M. Dolgova N. V. Vogt L. I. Quereshi M. Sokaras D. Kroll T. (2024). Synchrotron speciation of umbilical cord mercury and selenium after environmental exposure at Niigata. Neurotoxicology 100, 117–123. 10.1016/j.neuro.2023.12.011 38128735 Zhang X. Liu H. Wu X. Jia L. Gadhave K. Wang L. (2025). Lewy body dementia promotion by air pollution science 389(6764):eadu4132. 10.1126/science.adu4132 40906862 Zhou Y. Li H. Sun H. (2022). Metalloproteomics for biomedical research: methodology and applications. Annu. Rev. Biochem. 91, 449–473. 10.1146/annurev-biochem-040320-104628 35303792